The temporal-half retinas were dissected from the enucleated eyes, snap frozen on dry ice, and stored at −80°C for further assay. The retinas were homogenized in a buffer containing 10 mM HEPES (pH 7.2), 5 mM EGTA, 0.1% 3-([3-cholamidopropyl]dimethylammonio-2-hydroxy-1-propanesulfonate (CHAPS), 1.5 mM MgCl2, 5 mM DTT, 10 μg/mL pepstatin, 20 μg/mL leupeptin, 10 μg/mL aprotinin, and 0.5 mM PMSF. The samples were centrifuged at 20,000g for 20 minutes at 4°C, and usually 130 μg protein was transferred to an individual well of a 96-well plate and incubated with 50 μM of the synthetic substrate Acetyl-Asp-Glu-Val-Asp-4-methylcoumaryl-7-amide (Ac-DEVD-MCA; Peptide Institute, Osaka, Japan) in a solution containing 100 mM HEPES (pH 7.25), 10% sucrose, 0.1% CHAPS, 5 mM DTT, and 0.1% NP-40. The DEVD-MCA cleavage activity at 37°C was monitored by measuring excitation at 355 nm and emission at 460 nm on a plate reader (Fluoroscan Imaging Systems, Bedford, MA) over time. Fluorescent units were converted to picomoles of MCA released per minute, using a standard curve generated with free MCA.